价格

BOEHRINGER INGELHEIM PTY LTD

78 WATERLOO ROAD, Macquarie Park, New South Wales, 澳大利亚

别名:

altoria pharma

概览

试验阶段分布

阶段

试验数

占比

2 期

100.0%

试验状态分布

尚未招募

100.0%

药物批准

按机构分类的批准

TGA

Therapeutic Goods Administration

162

药物批准

近期批准

METALYSE tenecteplase (rch) 25 mg powder for injection vial (443530)

TGA

2025-07-15

METALYSE tenecteplase (rch) 25 mg powder for injection vial (443530)

TGA

2025-07-15

SPEVIGO spesolimab (rch) 450 mg in 7.5 mL concentrated solution for infusion vial (388597)

TGA

2023-11-24

SPEVIGO spesolimab (rch) 450 mg in 7.5 mL concentrated solution for infusion vial (388597)

TGA

2023-11-24

STRIVERDI RESPIMAT olodaterol (as hydrochloride) 2.5 microgram/actuation solution for inhalation cartridge (with dose indicator) (326012)

TGA

2020-04-17

STRIVERDI RESPIMAT olodaterol (as hydrochloride) 2.5 microgram/actuation solution for inhalation cartridge (with dose indicator) (326012)

TGA

2020-04-17

ESOVYND RESPIMAT tiotropium 2.5 micrograms/actuation solution for inhalation cartridge (with dose indicator) (325663)

TGA

2020-03-04

SRIVASSO RESPIMAT tiotropium 2.5 micrograms/actuation solution for inhalation cartridge (with dose indicator) (325664)

TGA

2020-03-04

SPIOLTO RESPIMAT 2.5 micrograms/2.5 micrograms tiotropium/olodaterol solution for inhalation cartridge (with dose indicator) (326008)

TGA

2020-03-04

YANIMO RESPIMAT 2.5 micrograms/2.5 micrograms tiotropium/olodaterol solution for inhalation cartridge (with dose indicator) (326009)

TGA

2020-03-04

资讯

暂无资讯文章

返回机构列表

BOEHRINGER INGELHEIM PTY LTD

概览

试验阶段分布

试验状态分布

相关临床试验

该机构主办的试验（1）

A study to test different doses of BI 730357 and find out the effect they have on symptoms in people with active psoriatic arthritis

药物批准

按机构分类的批准

近期批准

资讯